Viewing Study NCT07188103


Ignite Creation Date: 2025-12-24 @ 7:47 PM
Ignite Modification Date: 2025-12-25 @ 5:24 PM
Study NCT ID: NCT07188103
Status: RECRUITING
Last Update Posted: 2025-09-23
First Post: 2025-07-23
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Ivonescimab Plus Short-Course Hypofractionated Radiotherapy as Second-Line Therapy for Esophageal Squamous Cell Carcinoma
Sponsor: Anhui Provincial Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module